Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
Published April 30, 2014 · Recall initiated: February 20, 2014
Summary
FDA records drug Class III recall D-1246-2014, published April 30, 2014 and initiated February 20, 2014. Recalling firm: GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline; Status: Terminated; Reported quantity: 189,900 20 ct Vials, 145,068 81 ct Vials; Lot: (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15). Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
What to do
Voluntary: Firm initiated · Letter
Get an email if NICORETTE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NICORETTE
- Manufacturer
- GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
- Distributor
- U.S. Nationwide
- Lot
- (20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANicotine polacrilex lozenge, 2 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons.April 30, 2014
- FDANicotine polacrilex lozenge, 4 mg, Original Flavor, 72 count cartons, 81 count cartons, and 108 count cartons.April 30, 2014
- FDANicorette (nicotine polacrilex) Lozenges Mini, 2 mg, Original Flavor, 20 Lozenge, 27 Lozenge, 81 Lozenge andApril 30, 2014
- FDANicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mgApril 30, 2014
- FDANicorette Lozenge, Nicoderm CQ, and Nicorette Gum nicotine polacrilex combination. Contains 30 Pieces/ Pallet.April 30, 2014
- FDARezzRX capsules, Single Blister Pack and 20 count bottle, Distributed By: Fossil Fuel Products, LLC Atlanta,April 30, 2014
Questions about this recall
Was Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02. recalled?
Yes. FDA published recall D-1246-2014 on April 30, 2014. Reported hazard: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NICORETTE.